Supplements
boswellia decreases inflammation
In plain terms: Is boswellia actually anti-inflammatory?
Part of: 🧪 boswellia
Yes, with a real mechanism — its boswellic acids block a key inflammation enzyme (5-LOX), and a human trial showed it reduced brain swelling in cancer patients. The mechanism is solid; broad human 'lowers inflammation' data are still limited.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
Boswellia has a well-defined anti-inflammatory mechanism — its boswellic acids (esp. AKBA) inhibit 5-lipoxygenase, cutting pro-inflammatory leukotrienes — and a human RCT found it reduced cerebral edema in brain-tumour patients. Mechanistically solid and clinically plausible; direct human inflammatory-marker data are still limited.
The evidence (19)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Ammon 2010 · Phytomedicine | mechanism | mixed | low | Mechanistic review: boswellic acids modulate the immune system and inhibit leukotriene synthesis. |
| Zhao W et al 2025 · study_type: animal | animal | supports | moderate | Rat oral ulcer model; Boswellia extract accelerated healing and reduced inflammatory cell infiltration by shifting macrophage polarization from M1 to M2, decreasing pro-inflammatory cytokines via PPARγ. |
| Kirste 2011 · Cancer | RCT | supports | moderate | RCT: boswellia reduced cerebral edema in brain-tumour patients undergoing radiotherapy (human anti-inflammatory/anti-edema effect). |
| Mahto K et al 2025 · study_type: observational | observational | supports | moderate | Narrative review of Boswellia serrata in arthritis management; boswellic acids inhibit NF-κB, COX-2, and 5-LOX; cites preclinical and clinical studies showing reduced inflammation/pain and improved joint mobility. |
| Mukadam S et al 2026 · study_type: animal | animal | supports | moderate | Diabetic rat excision-wound model; topical Boswellia serrata-Zn gel significantly reduced IL-1β, IL-6, TNF-α, and MMP-9 in wound tissue by day 7 vs diabetic controls, alongside faster wound closure. |
| Nischang V et al 2025 · study_type: in-vitro | in-vitro | supports | moderate | Human M1/M2 macrophage cultures; two B. serrata extracts (differing AKBA content) both promoted a lipid-mediator class switch suppressing pro-inflammatory leukotrienes while increasing pro-resolving mediators. |
| Nguyen S et al 2025 · study_type: observational | observational | supports | low | Narrative review of lifestyle/supplement interventions for arthritis pain (2000-2025 literature); reports Boswellia showed 'modest benefits with favorable safety' alongside curcumin and glucosamine. |
| Sengupta 2011 · Mol Cell Biochem | mechanism | mixed | low | Mechanistic study: AKBA (Aflapin) inhibits 5-lipoxygenase and pro-inflammatory mediators. |
| Ammon 2006 · Planta Med | observational | mixed | low | Review: boswellic acids act on chronic inflammatory diseases via 5-lipoxygenase inhibition. |
| Abdel-Tawab 2011 · Clin Pharmacokinet | observational | supports | low | Assessment: boswellia is a plausible anti-inflammatory NSAID alternative, though bioavailability limits potency. |
| Stengler E et al 2026 · study_type: in-vitro | in-vitro | supports | moderate | Human airway cell (Air-Liquid-Interface) viral-mimicry and LPS-stimulated models; Boswellia serrata (H15 supplement) showed the strongest inhibition of pro-inflammatory cytokines among tested Burseraceae extracts. |
| Anis M et al 2026 · study_type: animal | animal | supports | moderate | Carrageenan-induced paw edema in rats; Boswellia serrata extract alone (400/800 mg/kg) significantly reduced inflammation dose-dependently (p<0.05) vs vehicle, with polyherbal combination showing greater effect. |
| Eid AM et al 2026 · study_type: in-vitro | in-vitro | supports | low | Boswellia sacra oil nanoemulgel tested against cancer cell lines and bacteria; IC50 for COX-1/COX-2 inhibition measured (4.36/1.40 µg/mL) as the anti-inflammatory readout. |
| Peng C et al 2025 · study_type: observational | observational | supports | low | Narrative review synthesizing preclinical and clinical evidence for boswellic acids' anti-inflammatory mechanisms (NF-κB, MAPK, 5-LOX, COX-2, NLRP3) and bioavailability challenges. |
| Roșca O et al 2025 · Preprints.org | animal | supports | low | Rat second-degree burn model (same dataset as PMID 40430888, preprint version); Boswellia serrata + Ocimum basilicum oleogel significantly reduced wound size and inflammation by days 9 and 21 (p<0.05). |
| Roșca OJ et al 2025 · study_type: animal | animal | supports | moderate | Rat second-degree scald burn model; topical formulations containing Boswellia serrata extract significantly reduced wound inflammation (erythema) and wound size vs other formulations by days 9 and 21 (p<0.05). |
| Mohamed ZA et al 2025 · Research Square | in-vitro | supports | low | Human chondrocyte cell line (C20A4); regular and nano-formulated Boswellia serrata methanol extract significantly suppressed IL1β, IL6, PGE2, and NF-kB inflammation biomarker gene expression. |
| Inferrera F et al 2025 · study_type: animal | animal | supports | moderate | Reserpine-induced fibromyalgia mouse model; oral Boswellia extract (100 mg/kg) reduced neuroinflammation markers (GFAP, Iba-1 glial activation) and oxidative stress, improving pain/behavioral outcomes. |
| Serafim FGS et al 2026 · study_type: animal | animal | supports | moderate | Rat models of gastric ulcer and acetic-acid colitis; Boswellia serrata dry extract (100-300 mg/kg) reduced macroscopic/microscopic colonic damage and inflammatory infiltration, plus oxidative stress markers. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.